Pharmaceutical Raw Materials
Veterinary API
Pharmaceutical Intermediates
Biochemicals
Pharmaceutical Excipients
Other Chemical Drugs
Blood System Drugs
Antineoplastic Agents
Nervous System Drugs
Respiratory Drugs
Antibiotics
Synthetic Anti Infective Drugs
Antipyretic Analgesics
Antiallergic Drugs
Fluid, Electrolyte, and Acid-Base Balance
Vitamins and Minerals Medicines
Urinary System Drugs
Digestive System Drugs
Antiparasitic Drugs
Anesthetic Agents
Hormones and Endocrine Drugs
Diagnostic Agents
Circulatory System Drugs
Immune System Medication
Anti Stress Drugs
Inhibitors
Drug Metabolism
Specialty Drugs
Feed Drug Additive
CAS:2023788-19-2
Molecular Formula:C225H348N48O68
Alias
More Information
GIP\GLP-1
Brief Introduction
Tirzepatide is a dual agonist of glucose dependent insulin nutritional polypeptide (GIP) and glucagon like peptide-1 (GLP-1) receptors, which is being developed for the treatment of type 2 diabetes. Compared with dulaglutide, Tirzepatide has significantly better efficacy in blood glucose control and weight loss.
Inquiry (
10
/ 10
)
Clear All
Sign In
Error!